Open this publication in new window or tab >>Show others...
2024 (English)In: Time-resolved methods in structural biology / [ed] Peter Moody; Hanna Kwon, Elsevier, 2024, p. 245-296Chapter in book (Refereed)
Abstract [en]
CoSAXS is a state-of-the-art SAXS/WAXS beamline exploiting the high brilliance of the MAX IV 3 GeV synchrotron. By coupling advances in sample environment control with fast X-ray detectors, millisecond time-resolved scattering methods can follow structural dynamics of proteins in solution. In the present work, four sample environments are discussed. A sample environment for combined SAXS with UV–vis and fluorescence spectroscopy (SUrF) enables a comprehensive understanding of the time evolution of conformation in a model protein upon acid-driven denaturation. The use of microfluidic chips with SAXS allows the mapping of concentration with very small sample volumes. For highly reproducible sequences of mixing of components, it is possible using stopped-flow and SAXS to access the initial effects of mixing at 2 millisecond timescales with good signal to noise to allow structural interpretation. The intermediate structures in a protein are explored under light and temperature perturbations by using lasers to "pump" the protein and SAXS as the "probe". The methods described demonstrate that features at low q, corresponding to cooperative motions of the atoms in a protein, could be extracted at millisecond timescales, which results from CoSAXS being a highly-stable, low background, dedicated SAXS beamline.
Place, publisher, year, edition, pages
Elsevier, 2024
Series
Methods in Enzymology, ISSN 0076-6879, E-ISSN 1557-7988 ; 709
Keywords
BioSAXS, CoSAXS, Fluorescence, Microfluidics, SAXS, Stopped-flow, Time-resolved SAXS, Time-resolved X-ray solution scattering, TR-XSS, UV–vis
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:umu:diva-231647 (URN)10.1016/bs.mie.2024.10.019 (DOI)39608946 (PubMedID)2-s2.0-85208024355 (Scopus ID)9780443314568 (ISBN)
Funder
Novo Nordisk Foundation, NNF20OC0065260Novo Nordisk Foundation, NNF22OC0080141
2024-11-192024-11-192025-03-05Bibliographically approved